IEEE Pulse · Jun 2026
Explains how SafeBeat’s beat-by-beat ECG AI supports transparent QTc measurement and clinician-directed cardiac therapy, with a focus on AF treatment workflows.
Guiding cardiac therapeutics - all from your phone
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Physician-led digital health company building explainable AI ECG software that turns FDA-cleared wearable data into remote therapeutic monitoring and treatment guidance for atrial fibrillation; the product is still under development and limited to investigational use only.
Primary product
Explainable AI ECG software for remote therapeutic monitoring and QTc / antiarrhythmic drug management
Founded
2020
Headquarters
Saint Louis, Missouri, United States
Team size
11-50
Work style
Flexible
Industry
Digital Health
Sub-industry
AI cardiac monitoring / remote therapeutic monitoring
Offices
Open Positions
0 jobs at SafeBeat
No open positions
Check back later for new openings